Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where I. Dianzani is active.

Publication


Featured researches published by I. Dianzani.


Journal of Inherited Metabolic Disease | 1996

Phenotype characterization and prevalence of rBAT M467T mutation in Italian cystinuric patients

L De Sanctis; M. Bruno; G Bonetti; D. Cosseddu; Luigi Bisceglia; A. Ponzone; I. Dianzani

Cystinuria (McKusick 220100) is an inherited disorder affecting the transport of cystine (Cys) and dibasic amino acids arginine (Arg), lysine (Lys) and ornithine (Orn) in the epithelial cells of both jejunum and proximal convoluted tubule, with an overall prevalence of 1 :7000. The only relevant consequence at clinical level is the urolithiasis due to the low solubility of Cys and the complications caused by renal stone disease. The occurrence of at least three distinct clinical types of cystinuria raises the question whether cystinuria is a single disease or a group of different conditions with impaired amino acid transport. Recently, a gene encoding a Cys and dibasic amino acid transporter (rBAT) has been identified (Bertran et al 1993) and several mutations in this gene have been found in cystinuric patients (Gasparini et al 1995). One mutation, M467T, was found to be prevalent in the Spanish population (40%) (Calonge et al 1994). The aim of this study was to analyse the phenotype distribution and the prevalence of rBAT M467T mutation in Italian cystinuric patients.


Pteridines | 1991

Molecular Basis of Phenylketonuria in Italy

I. Dianzani; Clara Camaschella; Giovanni Battista Ferrero; L. De Sanctis; A. Ponzone; R. G. H. Cotton

In recent years, a lot of data have been produced to elucidate the molecular basis of phenylketonuria (PKU), the disease caused by the deficiency of the liver enzyme phenylalanine hydroxylase (PAH). The identification of the RFLP haplotypes associated to the PAH gene has offered the means for prenatal diagnosis and carrier detection, previously infeasible or not always reliable by using biochemical methods. The characterization of the causal mutations may extend both these analyses, available only for selected families by RFLP studies, to the entire population. So far more than thirty mutations have been identified (ref. in 1 7). Most of the studies have been focussed on North European populations and for many of them 50 to 70% of the PKU causal mutations have been identified. On the other hand, the information about Mediterranean populations is scanty.


American Journal of Human Genetics | 1995

Molecular genetics of cystinuria : identification of four new mutations and seven polymorphisms, and evidence for genetic heterogeneity

Paolo Gasparini; María Julia Calonge; Luigi Bisceglia; Jesús Purroy; I. Dianzani; Angelo Notarangelo; Ferran Rousaud; M. Gallucci; Xavier Testar; Alberto Ponzone; Xavier Estivill; Antonio Zorzano; M Palacín; Virginia Nunes; Leopoldo Zelante


American Journal of Human Genetics | 1994

Genetic history of phenylketonuria mutations in Italy.

I. Dianzani; Sergio Giannattasio; L. de Sanctis; E. Marra; A. Ponzone; Clara Camaschella; A. Piazza


Minerva Biotecnologica | 2000

Genetic testing of hyperphenylalaninemias

I. Dianzani; L De Sanctis; Marco Spada; Alberto Ponzone


DEVELOPMENTAL BRAIN DYSFUNCTION | 1993

Prenatal diagnosis in primary hyperphenylalaninemias.

A. Ponzone; I. Dianzani; Marco Spada; L. De Sanctis; O. Guardamagna; E. Viora; R. Ponzone; L. Kierat; W. Leimbacher; A. Matasovic; Nenad Blau


Archive | 2004

Dihydropteridine Reductase De¢ciency in Man: From Biology toTreatment

Alberto Ponzone; Marco Spada; Silvio Ferraris; I. Dianzani; Luisa de Sanctis


American Journal of Human Genetics | 2002

Shortening of the bones of the hand in genetically characterized PHP-la patients.

L De Sanctis; Damiano Romagnolo; Andreo; Martina Olivero; I. Dianzani; C. de Sanctis


American Journal of Human Genetics | 2000

Albright hereditary osteodystrphy and pseudohypoparathyroidism: three new mutation and common deletion in GNAS1.

L De Sanctis; C Romagnolo De Sanctis; Roberto Lala; Martina Olivero; Mf Di Renzo; I. Dianzani


54° Congresso Nazionale della SIP: Società Italiana di Pediatria | 1998

diagnosi biochimica di eterozigosi per la fenilchetonuria.

Marco Spada; G Battistoni; G Bonetti; A Piccotti; F. Perfetto; S Baglieri; A Peduto; S Chiadò Cutin; L De Sanctis; I. Dianzani; A. Ponzone

Collaboration


Dive into the I. Dianzani's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Clara Camaschella

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

Luigi Bisceglia

Casa Sollievo della Sofferenza

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge